Liver Diseases  >>  cenicriviroc (TBR-652)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cenicriviroc (TBR-652) / Takeda, AbbVie
NCT02120547: Phase 1 Study of Multiple-Dose Pharmacokinetics of Cenicriviroc in Subjects With Mild and Moderate Hepatic Impairment

Completed
1
31
US
Cenicriviroc in mild liver impaired, CVC, Cenicriviroc in moderate liver impaired
Tobira Therapeutics, Inc.
Liver Insufficiency
07/14
08/14

Download Options